Robinhood: A Strong Business At A Difficult Entry Point
Tag: both professional investors
Healthcare ETFs: I Prefer VHT’s Growth To XLV’s Stability
Gilead Sciences: About To Break Out
ATRenew: The Market Is Ignoring The Improved Fundamentals
Investor Panic Creates A +10% Yield Opportunity: SLRC
American Tower: Well-Covered 4% Dividend Potentially Attractive For Income-Oriented Investors (Rating Downgrade)
Unusual Machines: Revenue Is Ready For Takeoff
Ginkgo Bioworks: Not There Yet
Portillo’s Selloff Is Likely To End Soon
Thomson Reuters: Look Beyond Disappointing FY2025 Prospects